Skip to main content
INIS
OTC Industrial Applications And Services

Radnostix Seeks Shareholder Approval for 2026 Incentive Plan with 12M Shares Amidst Going Concern Warning

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Pharmaceutical Stocks · Healthcare
Sentiment info
Negative
Importance info
7
Price
$0.079
Mkt Cap
$41.748M
52W Low
$0.04
52W High
$0.11
52W Position info
97% above low
Off High info
28% below high
Rel. Volume
Market data snapshot near publication time

INIS sits 97% above its 52-week low of $0.04.

Summary

Radnostix Inc. filed its definitive proxy statement for its annual meeting, seeking shareholder approval for a new equity incentive plan authorizing 12 million shares, representing 2.27% potential dilution, as the company continues to operate under a 'going concern' warning.


Key Events · Corporate Governance and Compliance · INIS

  • 2026 Incentive Plan Proposed

    The Board is seeking shareholder approval for a new equity incentive plan authorizing 12 million shares for awards, representing approximately 2.27% potential dilution of current outstanding shares. This plan is vital for employee retention and motivation amidst the company's financial challenges.

  • Executive Incentives Tied to High Stock Price Targets

    CEO Shahe Bagerdjian holds 37.5 million Restricted Stock Units (RSUs) with vesting conditions tied to the company's share price reaching levels between $0.10 and $0.30, significantly above the current stock price of $0.0789.

  • Ongoing Financial Distress

    The company continues to operate under a 'going concern' warning, having reported substantial net losses, lower revenue, product recalls, and the termination of a major asset sale in its recent 10-K and 10-Q filings.

  • Promissory Note Maturity Extensions

    Two related-party promissory notes from 2018 and 2019, involving former executives and major shareholders, had their maturity dates extended again to March 31, 2028, highlighting persistent financial strain.


Analysis · INIS · Industrial Applications And Services

Radnostix Inc. filed its definitive proxy statement for its annual shareholder meeting, proposing a new 2026 Incentive Plan that would authorize 12 million shares for equity awards. This represents a potential dilution of approximately 2.27% of current outstanding shares. The approval of such a plan is critical for the company to attract and retain employees and executives, especially given its severe financial distress, including a 'going concern' warning and significant net losses reported in recent filings. The CEO's existing RSU awards are tied to ambitious stock price targets, indicating a strong incentive for a substantial turnaround.

At the time of this filing, INIS was trading at $0.08 on OTC in the Industrial Applications And Services sector, with a market capitalization of approximately $41.7M. The 52-week trading range was $0.04 to $0.11. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

INIS - Latest Insights

INIS
Jul 02, 2026, 10:48 AM EDT
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $0.070
Real-time Price: $0.0702 info
Change: +$0.0002 (+0.29%) info
Market Cap: $37.145M info
INIS
Jul 01, 2026, 4:08 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $0.0714
Real-time Price: $0.0702 info
Change: -$0.0012 (-2%) info
Market Cap: $37.145M info
INIS
May 20, 2026, 3:36 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.083
Real-time Price: $0.0702 info
Change: -$0.0128 (-15%) info
Market Cap: $37.145M info
INIS
May 20, 2026, 2:36 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $0.080
Real-time Price: $0.0702 info
Change: -$0.0098 (-12%) info
Market Cap: $37.145M info
INIS
Apr 30, 2026, 2:53 PM EDT
Filing Type: 10-K/A
Importance Score:
7
Price at Filing: $0.0701
Real-time Price: $0.0702 info
Change: +$0.0001 (+0.14%) info
Market Cap: $37.145M info